The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

As per The Business Research Company’s Gastric Cancer Diagnostic Procedure Global Market Report 2023, the gastric cancer diagnostic procedure market is expected to show significant growth in the forecast period.

Key insights from the gastric cancer diagnostic procedure market forecast include:

1. Market Size

The worldwide gastric cancer diagnostic procedure market is projected to increase from $1.22 billion in 2022 to $1.32 billion in 2023, with an 8.3% CAGR. By 2027, the market size is anticipated to reach $1.75 billion, growing at a 7.2% CAGR.

2. Major Driver

The surge in gastrointestinal diseases propels the gastric cancer diagnostic procedure market. In June 2020, Global Cancer Observatory data revealed colorectal, gastric, and esophageal cancers accounted for a significant portion of cancer fatalities and new cases in 2020. Furthermore, an April 2020 American Gastroenterological Association survey, covering 33 countries, disclosed that over 40% of the 73,076 adult respondents worldwide had functional gastrointestinal disorders (FGID), impacting their quality of life and healthcare utilization. Consequently, the growing prevalence of gastrointestinal diseases drives market growth.

View More On The Gastric Cancer Diagnostic Procedure Market Report 2023 – https://www.thebusinessresearchcompany.com/report/gastric-cancer-diagnostic-procedure-global-market-report

3. Key Trend

Technological advancements are a notable trend in the gastric cancer diagnostic market. Leading companies in this sector embrace new technologies to maintain their competitive position. For example, in June 2022, Ibex Medical Analytics, an AI-powered diagnostics provider from Israel, introduced Galen Gastric, the world’s first AI-powered solution for gastric cancer detection. Galen Gastric is an integrated diagnostic tool that assists pathologists in identifying stomach cancer, H. pylori, and other key clinical findings, enhancing diagnostic workflows and turnaround times.

4. Largest Region

North America was the largest region in the gastric cancer diagnostics procedure market in 2022.

5. Major Players

Major players in the gastric cancer diagnostic procedure market are Pfizer Inc., Johnson & Johnson Co, F. Hoffmann La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories Inc., Sanofi SA, Eli Lilly and Company, Otsuka Pharmaceutical Co Ltd., AdventHealth, Atrium Health, Astellas Pharma Inc, Bausch Health Companies Inc., Agilent Technologies Inc., Ipsen Pharma, Hartford HealthCare, Myriad Genetics Inc., Myriad Genetics Inc., NovoCure Limited, Foundation Medicine Inc., and Biocept Inc.

Request A Sample Of The Global Gastric Cancer Diagnostic Procedure Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12038&type=smp

Key Gastric Cancer Diagnostic Procedure Market Segments
The global gastric cancer diagnostic procedure market is segmented –
1) By Procedure Type: Endoscopic Procedure, Biopsy, Tissue tests, Lab tests, In-vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics, Immunoassays, Other Procedure Types
2) By Symptom Type: Symptomatic, Asymptomatic
3) By Offering Type: Instruments, Reagents and Consumables, Services
4) By Body Fluid Type: Blood, Urine, Saliva, Stomach Juice, Tissue, Other Body Fluid
5) By Disease Indication: Early Gastric Cancer, Advanced Gastric Cancer

The Gastric Cancer Diagnostic Procedure Global Market Report 2023  provides an in-depth analysis on the gastric cancer diagnostic procedure market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the gastric cancer diagnostic procedure market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Gastric Cancer Drugs Global Market Report 2023
Gastric Volvulus Treatment Global Market Report 2023
Ovarian Cancer Diagnostics Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model